Follow $BNTX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BNTX by email
NASDAQ NMS - GLOBAL MARKET · BNTX
-7.99% · -$8.90 · Vol 3.2M
Market closed · last close 4:00 PM ET · price as of 19:02:59 ET
Biontech SE

Biontech SE

Biotechnology
$102.50
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
BNTX
Biontech SE
Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

47/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BNTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BNTX catalysts
About Biontech SE
Biotechnology
Listed since
2019
Employees
8K
Country
DE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$102.34
Day high
$105.23
Day low
$98.80
Previous close
$111.40
52W high
$119.34
-14.11% from high
52W low
$83.89
52% of range
Market cap
$25.6B
EPS
$-6.7095
Beta
0.41
Shares out
251.2M
Volume
3.2M
2.14× rel vol
Avg volume
1.5M
VWAP
$102.46
Price history computed in-house
1W
-12.07%
1M
+13.16%
3M
+11.78%
1Y
+2.50%
YTD
+7.67%
SMA 50 $95.27 · above
SMA 200 $97.75 · above
52W position 52%

BNTX overview

Veridion Score
47
Registered · 2026-08-28
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BNTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BNTX Form 4 filings
Public disclosures

Congress activity in BNTX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BNTX in the cached public ledger.

Federal contracts

BNTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BNTX in this window.
Lobbying spend

BNTX lobbying filings, year to date.

Registered lobbying filings matched to Biontech SE.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BNTX in this window.
Loading news for BNTX
Analyst ratings
Sovereign unlock shows live analyst consensus for BNTX.
Options
Sovereign unlock shows live options positioning for BNTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.